Chuck Triano
SVP, Investor Relations
Replay available
Bristol-Myers Squibb Company (BMY) Q4 2025 Earnings Call
Bristol-Myers Squibb Company (NYSE: BMY) Q4 2025 earnings conference call, held 2026-02-05. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Chris Boerner
Board Chair & Chief Executive Officer
David Elkins
Chief Financial Officer
Christian Massachese
Chief Medical Officer & Head of Global Drug Development
Adam Lankowski
Chief Commercialization Officer
Seamus Fernandez
Analyst, Guggenheim Securities
Chris Shaw
Analyst, J.P. Morgan
Michael Yee
Analyst, UBS
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Bristol-myers Squibb Company.
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.299 Welcome to Bristol-Myers Squibb Fourth Quarter 2025 Earnings Conference Call. 00:00:05.299 -- 00:00:08.123 All participants will be in listen-only mode. 00:00:08.123 -- 00:00:11.368 Should you need assistance, please signal a conference specialist by pressing the star 00:00:11.368 -- 00:00:13.651 key followed by zero. 00:00:13.651 -- 00:00:17.297 After today's presentation, there will be an opportunity to ask questions. 00:00:17.297 -- 00:00:21.303 To ask a question, you may press star then one on your telephone keypad, and to withdraw 00:00:21.303 -- 00:00:24.327 your question, please press star then two. 00:00:24.327 -- 00:00:27.909 Please note, today's event is being recorded. 00:00:32.228 -- 00:00:33.790 relations. 00:00:33.790 -- 00:00:35.990 Please go ahead. 00:00:36.133 -- 00:00:40.178 Thank you and good morning, everyone. We appreciate you joining our fourth quarter 2025 00:00:40.178 -- 00:00:45.205 earnings call. With me this morning with prepared remarks are Chris Berner, our board 00:00:45.205 -- 00:00:49.951 chair and chief executive officer, and David Elkins, our chief financial officer. 00:00:49.951 -- 00:00:55.178 Also participating in today's call is Adam Lankowski, our chief commercialization officer, 00:00:55.178 -- 00:01:00.882 and Christian Massachese, our chief medical officer and head of global drug development. 00:01:00.882 -- 00:01:05.809 Earlier this morning, we posted our quarterly slide presentation to bms.com 00:01:05.809 -- 00:01:10.115 that you can use to follow along with Chris and David's remarks. 00:01:10.115 -- 00:01:14.121 Before we get started, I'll remind everybody that during this call, we will make statements 00:01:14.121 -- 00:01:19.649 about the company's future plans and prospects that cons...